CALIFORNIA’S HIGHEST-PAID EXECUTIVES : Buyout Boon

G. Kirk Raab and several other executives at San Francisco-based Genentech won big when the company merged with Roche Holdings last year. When Roche bought 60% of Genentech’s stock, it also purchased unexercised stock options from executives. Raab earned $6.3 million on the deal. Robert Swanson, also of Genentech, got $4.5 million for not exercising his stock options.